JP2022500034A5 - - Google Patents
Info
- Publication number
- JP2022500034A5 JP2022500034A5 JP2021513327A JP2021513327A JP2022500034A5 JP 2022500034 A5 JP2022500034 A5 JP 2022500034A5 JP 2021513327 A JP2021513327 A JP 2021513327A JP 2021513327 A JP2021513327 A JP 2021513327A JP 2022500034 A5 JP2022500034 A5 JP 2022500034A5
- Authority
- JP
- Japan
- Prior art keywords
- peptides
- cells
- antigen
- library
- peptide
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862729220P | 2018-09-10 | 2018-09-10 | |
| US62/729,220 | 2018-09-10 | ||
| US201962884527P | 2019-08-08 | 2019-08-08 | |
| US62/884,527 | 2019-08-08 | ||
| PCT/US2019/050492 WO2020055931A1 (en) | 2018-09-10 | 2019-09-10 | Antigen-specific t lymphocytes and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500034A JP2022500034A (ja) | 2022-01-04 |
| JP2022500034A5 true JP2022500034A5 (https=) | 2022-09-21 |
| JPWO2020055931A5 JPWO2020055931A5 (https=) | 2022-09-21 |
Family
ID=69778456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513327A Withdrawn JP2022500034A (ja) | 2018-09-10 | 2019-09-10 | 抗原特異的ｔリンパ球ならびに抗原特異的ｔリンパ球を作製および使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220033766A1 (https=) |
| EP (1) | EP3849569A4 (https=) |
| JP (1) | JP2022500034A (https=) |
| AU (1) | AU2019339332A1 (https=) |
| CA (1) | CA3112471A1 (https=) |
| IL (1) | IL281339A (https=) |
| WO (1) | WO2020055931A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230190902A1 (en) * | 2020-05-29 | 2023-06-22 | Children's National Medical Center | Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame |
| US20260041747A1 (en) | 2022-07-29 | 2026-02-12 | Repertoire Immune Medicines, Inc. | T cell epitopes associated with type 1 diabetes |
| EP4605422A2 (en) | 2022-10-20 | 2025-08-27 | Repertoire Immune Medicines, Inc. | Cd8 t cell targeted il2 |
| WO2025072849A1 (en) | 2023-09-29 | 2025-04-03 | Repertoire Immune Medicines, Inc. | Mhc-presentable peptides associated with type 1 diabetes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007017201A1 (en) * | 2005-08-05 | 2007-02-15 | Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh | Generation of antigen specific t cells |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| WO2012112689A1 (en) | 2011-02-15 | 2012-08-23 | The University Of North Carolina At Chapel Hill | Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers |
| EP3049114B1 (en) | 2013-09-27 | 2021-11-10 | Massachusetts Institute of Technology | Carrier-free biologically-active protein nanostructures |
| EP3169352A1 (en) * | 2014-07-15 | 2017-05-24 | Immune Design Corp. | Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector |
| CN108990413A (zh) | 2015-08-12 | 2018-12-11 | 麻省理工学院 | 纳米颗粒的细胞表面偶联 |
-
2019
- 2019-09-10 EP EP19859995.3A patent/EP3849569A4/en not_active Withdrawn
- 2019-09-10 AU AU2019339332A patent/AU2019339332A1/en not_active Abandoned
- 2019-09-10 WO PCT/US2019/050492 patent/WO2020055931A1/en not_active Ceased
- 2019-09-10 US US17/274,943 patent/US20220033766A1/en not_active Abandoned
- 2019-09-10 JP JP2021513327A patent/JP2022500034A/ja not_active Withdrawn
- 2019-09-10 CA CA3112471A patent/CA3112471A1/en active Pending
-
2021
- 2021-03-09 IL IL281339A patent/IL281339A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Den Haan et al. | CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo | |
| Silk et al. | Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy | |
| Ahlers et al. | High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection | |
| JP2022500034A5 (https=) | ||
| JP5127224B2 (ja) | 予防又は治療目的のためのｍｈｃクラスｉ拘束性エピトープに対する免疫応答を誘発し、増強し、維持する方法 | |
| Galea-Lauri et al. | Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination | |
| CN100337686C (zh) | 从前体产生加载有抗原的树突细胞疫苗的快速一步法 | |
| Okada et al. | Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens | |
| NL2009102C2 (en) | Method for dc-loading. | |
| JP2002504322A (ja) | 樹状細胞に対するアポトーシス細胞介在抗原提示 | |
| US20020155108A1 (en) | Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells | |
| AU2008303453B2 (en) | An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases | |
| CA2348956A1 (en) | Immunotherapeutic methods using epitopes of wt-1 and gata-1 | |
| EP3424522A1 (en) | System and method of preparing and storing activated mature dendritic cells | |
| US20140141046A1 (en) | Method and composition for producing a cellular allogeneic vaccine | |
| JP2011504101A5 (https=) | ||
| JP5016489B2 (ja) | 抗原提示ヒトγδＴ細胞の調製及び免疫療法における使用 | |
| Dhodapkar et al. | Active immunization of humans with dendritic cells | |
| US20230357718A1 (en) | Methods and materials for expanding antigen-specific t cells in culture | |
| Reichardt et al. | Dendritic cells in vaccination therapies of human malignant disease | |
| CN1353575A (zh) | 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t－销细胞 | |
| JP2023539056A (ja) | Ｔ細胞を製造する組成物および方法 | |
| Tirapu et al. | Cytokine gene transfer into dendritic cells for cancer treatment | |
| US7837990B2 (en) | In vivo expanded NKT cells and methods of use thereof | |
| Cohen et al. | Use of interleukin-7, interleukin-2, and interferon-γ to propagate CD4+ T cells in culture with maintained antigen specificity |